DE1813241C3 - - Google Patents
Info
- Publication number
 - DE1813241C3 DE1813241C3 DE19681813241 DE1813241A DE1813241C3 DE 1813241 C3 DE1813241 C3 DE 1813241C3 DE 19681813241 DE19681813241 DE 19681813241 DE 1813241 A DE1813241 A DE 1813241A DE 1813241 C3 DE1813241 C3 DE 1813241C3
 - Authority
 - DE
 - Germany
 - Prior art keywords
 - pyridyl
 - yield
 - theory
 - methyl
 - bromoindole
 - Prior art date
 - Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
 - Expired
 
Links
- 238000000034 method Methods 0.000 claims description 12
 - 238000002360 preparation method Methods 0.000 claims description 3
 - HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 26
 - QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
 - XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
 - LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
 - 239000000243 solution Substances 0.000 description 16
 - RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
 - 239000000203 mixture Substances 0.000 description 15
 - UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
 - XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
 - ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
 - VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
 - 239000000725 suspension Substances 0.000 description 10
 - PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
 - SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 9
 - -1 1-substituted benzodiazepinones Chemical class 0.000 description 8
 - QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
 - 239000011541 reaction mixture Substances 0.000 description 8
 - 229910052938 sodium sulfate Inorganic materials 0.000 description 8
 - 235000011152 sodium sulphate Nutrition 0.000 description 8
 - 239000002904 solvent Substances 0.000 description 8
 - 150000001875 compounds Chemical class 0.000 description 7
 - 238000001816 cooling Methods 0.000 description 7
 - 238000002844 melting Methods 0.000 description 7
 - 230000008018 melting Effects 0.000 description 7
 - 239000002244 precipitate Substances 0.000 description 7
 - 238000001953 recrystallisation Methods 0.000 description 7
 - ZHYMGSPDEVXULU-UHFFFAOYSA-N 1,2-benzodiazepin-3-one Chemical class N1=NC(=O)C=CC2=CC=CC=C21 ZHYMGSPDEVXULU-UHFFFAOYSA-N 0.000 description 6
 - CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 6
 - YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
 - 239000002026 chloroform extract Substances 0.000 description 5
 - PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 5
 - RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 5
 - 230000003647 oxidation Effects 0.000 description 5
 - 238000007254 oxidation reaction Methods 0.000 description 5
 - NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
 - VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
 - 235000011114 ammonium hydroxide Nutrition 0.000 description 4
 - 238000006243 chemical reaction Methods 0.000 description 4
 - 239000013078 crystal Substances 0.000 description 4
 - 239000000706 filtrate Substances 0.000 description 4
 - 239000005457 ice water Substances 0.000 description 4
 - 239000000155 melt Substances 0.000 description 4
 - 239000007800 oxidant agent Substances 0.000 description 4
 - 238000003756 stirring Methods 0.000 description 4
 - FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
 - RNAODKZCUVVPEN-UHFFFAOYSA-N 1h-indol-2-ylmethanamine Chemical compound C1=CC=C2NC(CN)=CC2=C1 RNAODKZCUVVPEN-UHFFFAOYSA-N 0.000 description 3
 - WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
 - OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
 - KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
 - CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
 - HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
 - QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
 - ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
 - 229940117975 chromium trioxide Drugs 0.000 description 3
 - WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 3
 - GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 3
 - 239000012259 ether extract Substances 0.000 description 3
 - 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
 - 150000002475 indoles Chemical class 0.000 description 3
 - 238000010992 reflux Methods 0.000 description 3
 - 150000003839 salts Chemical class 0.000 description 3
 - CBTITARLOCZPDU-UHFFFAOYSA-N 1h-indole-2-carbonitrile Chemical compound C1=CC=C2NC(C#N)=CC2=C1 CBTITARLOCZPDU-UHFFFAOYSA-N 0.000 description 2
 - IPONLHAIQBCUCY-UHFFFAOYSA-N 1h-indole;dihydrochloride Chemical compound Cl.Cl.C1=CC=C2NC=CC2=C1 IPONLHAIQBCUCY-UHFFFAOYSA-N 0.000 description 2
 - ZIWZCDRHKRIADU-UHFFFAOYSA-N 2-amino-n-(2-benzoylphenyl)acetamide Chemical class NCC(=O)NC1=CC=CC=C1C(=O)C1=CC=CC=C1 ZIWZCDRHKRIADU-UHFFFAOYSA-N 0.000 description 2
 - BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
 - CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
 - OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
 - HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical class C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 description 2
 - KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
 - JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
 - WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
 - 239000002253 acid Substances 0.000 description 2
 - 229940054051 antipsychotic indole derivative Drugs 0.000 description 2
 - KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
 - AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 2
 - 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
 - IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
 - 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
 - 239000012280 lithium aluminium hydride Substances 0.000 description 2
 - 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
 - FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
 - XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
 - BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
 - 239000007858 starting material Substances 0.000 description 2
 - 125000001424 substituent group Chemical group 0.000 description 2
 - VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
 - WEWXXYDHYCDEKY-UHFFFAOYSA-N (2-aminophenyl)-pyridin-2-ylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=N1 WEWXXYDHYCDEKY-UHFFFAOYSA-N 0.000 description 1
 - TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 description 1
 - ARHAUAHAFMYQCN-UHFFFAOYSA-N (3-phenyl-1h-indol-2-yl)methanamine Chemical class NCC=1NC2=CC=CC=C2C=1C1=CC=CC=C1 ARHAUAHAFMYQCN-UHFFFAOYSA-N 0.000 description 1
 - HCUARRIEZVDMPT-UHFFFAOYSA-M 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)[O-])=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-M 0.000 description 1
 - XMQRITNQHRYLBY-UHFFFAOYSA-N 2-amino-N-[2-(pyridine-2-carbonyl)phenyl]acetamide Chemical class NCC(=O)NC1=C(C(=O)C2=NC=CC=C2)C=CC=C1 XMQRITNQHRYLBY-UHFFFAOYSA-N 0.000 description 1
 - KRIMUINWKILYBE-UHFFFAOYSA-N 2-oxo-3-pyridin-2-ylpropanoic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=N1 KRIMUINWKILYBE-UHFFFAOYSA-N 0.000 description 1
 - IVUAAOBNUNMJQC-UHFFFAOYSA-N 5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one Chemical class C12=CC=CC=C2NC(=O)CN=C1C1=CC=CC=C1 IVUAAOBNUNMJQC-UHFFFAOYSA-N 0.000 description 1
 - QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
 - RJOJNGPHVYBYKD-UHFFFAOYSA-N BrCC(=O)NC1=C(C(=NC=C1)C(=O)C1=NC=CC(=C1C1=CC=CC=C1)NC(CBr)=O)C1=CC=CC=C1 Chemical compound BrCC(=O)NC1=C(C(=NC=C1)C(=O)C1=NC=CC(=C1C1=CC=CC=C1)NC(CBr)=O)C1=CC=CC=C1 RJOJNGPHVYBYKD-UHFFFAOYSA-N 0.000 description 1
 - WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
 - KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
 - XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
 - CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
 - MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
 - DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
 - 229910002651 NO3 Inorganic materials 0.000 description 1
 - NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
 - KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
 - FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
 - QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
 - DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
 - 230000002378 acidificating effect Effects 0.000 description 1
 - 230000009435 amidation Effects 0.000 description 1
 - 238000007112 amidation reaction Methods 0.000 description 1
 - 150000001408 amides Chemical class 0.000 description 1
 - 150000001412 amines Chemical class 0.000 description 1
 - 125000003277 amino group Chemical group 0.000 description 1
 - 229910021529 ammonia Inorganic materials 0.000 description 1
 - 230000002921 anti-spasmodic effect Effects 0.000 description 1
 - 229940124575 antispasmodic agent Drugs 0.000 description 1
 - 239000007864 aqueous solution Substances 0.000 description 1
 - QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
 - 238000009835 boiling Methods 0.000 description 1
 - 244000309464 bull Species 0.000 description 1
 - 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
 - 239000000460 chlorine Chemical group 0.000 description 1
 - 229910052801 chlorine Inorganic materials 0.000 description 1
 - 238000009833 condensation Methods 0.000 description 1
 - 230000005494 condensation Effects 0.000 description 1
 - 238000000354 decomposition reaction Methods 0.000 description 1
 - 230000018044 dehydration Effects 0.000 description 1
 - 238000006297 dehydration reaction Methods 0.000 description 1
 - 125000004989 dicarbonyl group Chemical group 0.000 description 1
 - 238000004090 dissolution Methods 0.000 description 1
 - RUDKNKYELWRKKA-UHFFFAOYSA-N ethyl 2-oxo-3-pyridin-2-ylpropanoate Chemical compound CCOC(=O)C(=O)CC1=CC=CC=N1 RUDKNKYELWRKKA-UHFFFAOYSA-N 0.000 description 1
 - RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
 - 239000012458 free base Substances 0.000 description 1
 - 239000007789 gas Substances 0.000 description 1
 - 150000002391 heterocyclic compounds Chemical class 0.000 description 1
 - 239000001257 hydrogen Substances 0.000 description 1
 - 229910052739 hydrogen Inorganic materials 0.000 description 1
 - 238000005984 hydrogenation reaction Methods 0.000 description 1
 - 239000003326 hypnotic agent Substances 0.000 description 1
 - 230000000147 hypnotic effect Effects 0.000 description 1
 - INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
 - 238000002955 isolation Methods 0.000 description 1
 - 230000011987 methylation Effects 0.000 description 1
 - 238000007069 methylation reaction Methods 0.000 description 1
 - 239000012452 mother liquor Substances 0.000 description 1
 - 229940035363 muscle relaxants Drugs 0.000 description 1
 - 239000003158 myorelaxant agent Substances 0.000 description 1
 - 230000007935 neutral effect Effects 0.000 description 1
 - 230000001590 oxidative effect Effects 0.000 description 1
 - 239000001301 oxygen Substances 0.000 description 1
 - 229910052760 oxygen Inorganic materials 0.000 description 1
 - 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
 - HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
 - 229940067157 phenylhydrazine Drugs 0.000 description 1
 - CFZKDDTWZYUZKS-UHFFFAOYSA-N picoline N-oxide Chemical compound CC1=CC=CC=[N+]1[O-] CFZKDDTWZYUZKS-UHFFFAOYSA-N 0.000 description 1
 - 229910000027 potassium carbonate Inorganic materials 0.000 description 1
 - 239000000047 product Substances 0.000 description 1
 - 238000000746 purification Methods 0.000 description 1
 - UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
 - 125000004076 pyridyl group Chemical group 0.000 description 1
 - 125000000168 pyrrolyl group Chemical group 0.000 description 1
 - 230000009257 reactivity Effects 0.000 description 1
 - 238000006798 ring closing metathesis reaction Methods 0.000 description 1
 - 238000006049 ring expansion reaction Methods 0.000 description 1
 - 238000007363 ring formation reaction Methods 0.000 description 1
 - 239000011734 sodium Substances 0.000 description 1
 - 229910052708 sodium Inorganic materials 0.000 description 1
 - 229910000029 sodium carbonate Inorganic materials 0.000 description 1
 - 239000012312 sodium hydride Substances 0.000 description 1
 - 229910000104 sodium hydride Inorganic materials 0.000 description 1
 - 238000006467 substitution reaction Methods 0.000 description 1
 - YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
 - 239000003204 tranquilizing agent Substances 0.000 description 1
 - 230000002936 tranquilizing effect Effects 0.000 description 1
 - 238000005406 washing Methods 0.000 description 1
 
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| JP7890667 | 1967-12-08 | ||
| JP7890667 | 1967-12-08 | ||
| JP7916867 | 1967-12-09 | ||
| JP7916867 | 1967-12-09 | ||
| JP7992267 | 1967-12-12 | ||
| JP7992167 | 1967-12-12 | ||
| JP7992167 | 1967-12-12 | ||
| JP7992267 | 1967-12-12 | ||
| JP2817268 | 1968-04-25 | ||
| JP2817268 | 1968-04-25 | 
Publications (3)
| Publication Number | Publication Date | 
|---|---|
| DE1813241A1 DE1813241A1 (de) | 1969-07-03 | 
| DE1813241B2 DE1813241B2 (de) | 1977-06-16 | 
| DE1813241C3 true DE1813241C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1978-02-02 | 
Family
ID=27521009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| DE19681813241 Granted DE1813241B2 (de) | 1967-12-08 | 1968-12-06 | Verfahren zur herstellung von 1,3- dihydro-5-(2'pyridyl)-2h-1,4-benzodiazepin- 2-on-derivaten | 
Country Status (8)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| DE3124013A1 (de) * | 1981-06-19 | 1982-12-30 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | 
- 
        1968
        
- 1968-11-29 US US780207A patent/US3560482A/en not_active Expired - Lifetime
 - 1968-12-04 GB GB57654/68A patent/GB1197138A/en not_active Expired
 - 1968-12-06 DE DE19681813241 patent/DE1813241B2/de active Granted
 - 1968-12-06 NL NL686817507A patent/NL142959B/xx not_active IP Right Cessation
 - 1968-12-06 FR FR1594179D patent/FR1594179A/fr not_active Expired
 - 1968-12-09 CH CH1835768A patent/CH502355A/de not_active IP Right Cessation
 - 1968-12-09 SE SE16833/68A patent/SE352637B/xx unknown
 - 1968-12-09 BE BE725160D patent/BE725160A/xx not_active IP Right Cessation
 
 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| DE1920207B2 (de) | Verfahren zur herstellung von 1,3- dihydro-2h-1,4-benzodiazepin-2-onderivaten | |
| DE1812231C3 (de) | Verfahren zur Herstellung von 3-Alkyl- 5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-onderivaten | |
| DE1813241C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| Lawson et al. | 574. Some new mesoionic compounds | |
| DE1935671C3 (de) | 2-Aminomethylindole und ihre Salze | |
| DE1813241B2 (de) | Verfahren zur herstellung von 1,3- dihydro-5-(2'pyridyl)-2h-1,4-benzodiazepin- 2-on-derivaten | |
| DE1770421C3 (de) | Verfahren zur Herstellung von 1,3-Dihydro-2H-1,4-benzodiazepin-2-onderivaten | |
| DE1817791C3 (de) | 2-Aminomethyl-3-phenylindole und ihre Salze mit Säuren | |
| CH612186A5 (en) | Process for the preparation of 2(1H)-quinazolinone derivatives | |
| DE3129718A1 (de) | 4-oximino-1,2,3,4-tetrahydrochinolinderivate und verfahren zu ihrer herstellung | |
| DE1806106C3 (de) | Verfahren zur Herstellung von 7-Nitro-5-pheny 1-1,3-dihydro-2H-1,4-benzodiazepin-2-on-derivaten | |
| DE1814332C3 (de) | Verfahren zur Herstellung von 1,5-Benzo-diazocinen oder 1,6-Benzodiazoninen | |
| DE1770420C3 (de) | Verfahren zur Herstellung von 1,3-Dihydro-2H-1,4-benzodiazepin-2-onderivaten | |
| DE2065719C2 (de) | 1-Niederalkyl-substituierte 6,7-Methylendioxy-4(1H)-oxocinnolin-3-carbonitrile | |
| DE1918311C3 (de) | Verfahren zur Herstellung von l-Carbamoylalkyl-l.S-dihydro^H-Mbenzodiazepin-2-on-derivaten | |
| DE1817761C3 (de) | 2-Aminomethyl-3-phenyl-5-nitroindole und ihre Salze | |
| AT252924B (de) | Verfahren zur Herstellung von neuen Benzodiazepinderivaten | |
| DE1770177A1 (de) | Monoaryl-substituierte Oxazole | |
| DE1795372C3 (de) | 10.01.68 Japan 1501-68 Verfahren zur Herstellung von 5-(o-Halogenphenyl)-7-halogen-1,3-dihydro-2H-1,4-benzodiazepin-2-onen und 2-Aminomethylindole und ihre Salze | |
| DE2065707C3 (de) | Gama-Piperidino-2-halobutyrophenon-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE1811830C3 (de) | Verfahren zur Herstellung von 7-Nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on-derivaten | |
| DE1770420B2 (de) | Verfahren zur Herstellung von 1,3-Dihydro-2H-1,4-benzodiazepin-2-on-derivaten | |
| AT236386B (de) | Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten | |
| AT296316B (de) | Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten und deren N-4-Oxyden | |
| DE2033909C3 (de) | Verfahren zur Herstellung von gamma-Piperidinobutyrophenon-Derivaten |